AUDUBON, Pa., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company,
today announced the first spine surgeries using ExcelsiusGPS™, a revolutionary robotic guidance and navigation system. Surgeries
using ExcelsiusGPS™ were performed last week at The Johns Hopkins Hospital in Baltimore, Maryland and St. Mark’s Hospital in Salt
Lake City, Utah. The surgical team at Johns Hopkins was led by neurosurgeons Dr. Nick Theodore and Dr. Ali Bydon, while
orthopedic spine surgeon Dr. Kade Huntsman performed the surgeries at St. Marks.
“ExcelsiusGPS™ is the only robotic system that combines surgical navigation and robotic guidance for spinal
surgery, which offers significant advantages to spine surgeons,” said Dr. Huntsman, “The system has been designed to take into
account the typical surgical workflow to facilitate procedural efficiency.”
“ExcelsiusGPS™ is the culmination of years of research and development efforts and demonstrates Globus
Medical's superior product development capabilities,” said Norbert Johnson, Vice President of Robotics, Imaging, & Navigation.
“We believe the ExcelsiusGPS™ System will advance patient care and provide tangible benefits for surgeons and
hospitals in terms of time, accuracy and reduced radiation exposure through the application of robotic and
navigation technology in spine and orthopedic surgery.”
ExcelsiusGPS™ supports minimally invasive and open screw placement procedures. It seamlessly integrates Globus
Medical implants and instruments and is compatible with pre-operative CT, intra-operative CT and fluoroscopic imaging modalities.
The system is designed to minimize radiation exposure, streamline workflow, and reproducibly assist in implant placement.
Globus Medical expects its first revenues from the sale of ExcelsiusGPS™ systems to occur in the fourth quarter
2017, in alignment with current company guidance.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by
an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients
with musculoskeletal disorders.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements
and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,”
“anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current
assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are
subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results
to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability
to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to successfully integrate the international operations acquired from
Alphatec, both in general and on our anticipated timeline, our ability to transition Alphatec’s international customers to Globus
Medical products, our ability to realize the expected benefits to our results from the Alphatec acquisition, our ability to comply
with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results,
you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at
www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to
time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on
our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue
reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the
date of this press release. We undertake no obligation to update any forward-looking statements as a result of new
information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contact:
Daniel Scavilla
Senior Vice President, Chief Financial Officer
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com